AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 295: E227-E237, 2008. First published April 8, 2008; doi:10.1152/ajpendo.90245.2008
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/E227    most recent
90245.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Douard, V.
Right arrow Articles by Ferraris, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Douard, V.
Right arrow Articles by Ferraris, R. P.

REVIEWS

Regulation of the fructose transporter GLUT5 in health and disease

Veronique Douard and Ronaldo P. Ferraris

Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey

Submitted 20 February 2008 ; accepted in final form 27 March 2008

ABSTRACT

Fructose is now such an important component of human diets that increasing attention is being focused on the fructose transporter GLUT5. In this review, we describe the regulation of GLUT5 not only in the intestine and testis, where it was first discovered, but also in the kidney, skeletal muscle, fat tissue, and brain where increasing numbers of cell types have been found to have GLUT5. GLUT5 expression levels and fructose uptake rates are also significantly affected by diabetes, hypertension, obesity, and inflammation and seem to be induced during carcinogenesis, particularly in the mammary glands. We end by highlighting research areas that should yield information needed to better understand the role of GLUT5 during normal development, metabolic disturbances, and cancer.

cancer; diabetes; diet; hypertension; inflammation; metabolic syndrome



Address for reprint requests and other correspondence: R. P. Ferraris, Dept. of Pharmacology and Physiology, UMDNJ - New Jersey Medical School, 185 South Orange Ave., Newark, NJ 07101




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Schmidt, H.-G. Joost, and A. Schurmann
GLUT8, the enigmatic intracellular hexose transporter
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E614 - E618.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Schurmann
Insight into the "odd" hexose transporters GLUT3, GLUT5, and GLUT7
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E225 - E226.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.